Latest Leadership Updates News

Celsius Resources has locked in a USD 76.4 million bridge loan from the Philippine sovereign wealth fund to advance early development of its flagship MCB copper-gold project, while raising A$3.3 million through a share placement to bolster its balance sheet.

Energy World Corporation has appointed a global investment bank to spearhead funding efforts for its LNG and power projects in the Philippines, while reporting a $3.62 million operating cash outflow and the resignation of a senior executive.

Emperor Energy has submitted a key Environmental Plan to NOPSEMA, marking a major step towards drilling the Judith-2 appraisal well in mid-2026 amid tightening east coast gas supply. The company also appointed industry veteran Douglas Jendry as Chairman to steer its next phase.

KGL Resources has reported a robust quarterly update for its Jervois Copper Project, highlighting a strong feasibility study with a $405 million NPV and successful drilling that extends high-grade copper resources. The company also secured $4.2 million in new capital and is progressing strategic financing to target production by 2027.

Bastion Minerals Limited has announced the immediate departure of CEO Allister Caird, with directors Gavin Ross and Keith Rutherford stepping in to support a smooth transition during a three-month handover period.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

Evolution Mining Limited has reported a record statutory net profit after tax of $365.1 million for the half-year ended December 31, 2024, driven by strong operational performance and higher gold and copper prices. The company also declared a fully franked interim dividend of 7.0 cents per share, continuing its consistent shareholder returns.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.

Coda Minerals has significantly enhanced the economic outlook of its Elizabeth Creek Copper-Cobalt Project, with a pre-tax NPV7 rising to $1.18 billion and a post-tax NPV7 increase of 57% to $802 million. The company also secured $5.1 million in fresh capital to accelerate exploration and drilling activities in 2025.

Askari Metals reports significant exploration advances across its Australian gold and copper projects and secures a new uranium project in Tanzania, supported by fresh funding and leadership updates.

Neurotech International reports key clinical progress in paediatric neurological disorders, securing FDA orphan drug designation for its Rett Syndrome treatment and advancing pivotal trials for ASD and PANDAS/PANS.